Biotech | December 11, 2021
Alembic acquires stake in RIGlmmune
The company is focused on the development of novel treatments for RNA viruses
The company is focused on the development of novel treatments for RNA viruses
Brii Bio announces amubarvimab/romlusevimab combination received approval from NMPA
Saroglitazar Mg is an investigational compound in the USA, and is yet to be approved by the U.S. Food & Drug Administration (USFDA) or European Medicines Agency (EMA)
An MoU was signed between B Medical Systems and Gujarat government recently
Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants
It plans to add over 1000 employees over the next six months
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
Sputnik M is a new member of the Sputnik vaccines family
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Subscribe To Our Newsletter & Stay Updated
